What is Cheribundi?
Founded in 2006 and headquartered in Geneva, New York, Cheribundi specializes in producing tart cherry juices that are all-natural and not from concentrate. The company has established itself as a key player in the health and wellness beverage sector, leveraging the perceived health benefits of tart cherries. Its product line caters to consumers seeking natural, functional beverages, positioning Cheribundi as a notable entity within the natural foods industry.
How much funding has Cheribundi raised?
Cheribundi has raised a total of $33.8M across 6 funding rounds:
Private Equity
$2M
Private Equity
$4.5M
Debt
$1.3M
Private Equity
$1.9M
Private Equity
$9.2M
Series B
$15M
Private Equity (2009): $2M, investors not publicly disclosed
Private Equity (2012): $4.5M, investors not publicly disclosed
Debt (2013): $1.3M, investors not publicly disclosed
Private Equity (2014): $1.9M, investors not publicly disclosed
Private Equity (2016): $9.2M, investors not publicly disclosed
Series B (2020): $15M with participation from Emil Capital Partners LLC
Key Investors in Cheribundi
Emil Capital Partners LLC
Emil Capital Partners LLC is a private investment firm. Their participation suggests a strategic alignment with Cheribundi's growth objectives, likely focusing on operational enhancements and market expansion.
What's next for Cheribundi?
The recent major strategic investment signals a pivotal moment for Cheribundi, likely enabling further scaling of operations, market penetration, and product innovation. This enterprise-level funding suggests a focus on expanding distribution channels and potentially developing new product lines or enhancing existing ones. Cheribundi's strategic financing indicates a strong market position and investor confidence in its future growth and profitability within the competitive beverage landscape.
See full Cheribundi company page
